Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Parkinson's Disease

  Free Subscription


06.06.2022

1 Brain Res
1 J Neural Transm (Vienna)
2 Mov Disord
2 Neurobiol Dis
2 Neurologia (Engl Ed)
1 Neurology
1 Neuron
1 Rev Neurol


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Brain Res

  1. ISHOLA IO, Awogbindin IO, Olubodun-Obadun TG, Oluwafemi OA, et al
    Morin ameliorates rotenone-induced Parkinson disease in mice through antioxidation and anti-neuroinflammation: gut-brain axis involvement.
    Brain Res. 2022 May 30:147958. doi: 10.1016/j.brainres.2022.147958.
    PubMed         Abstract available


    J Neural Transm (Vienna)

  2. EKLUND M, Nuuttila S, Joutsa J, Jaakkola E, et al
    Diagnostic value of micrographia in Parkinson's disease: a study with [(123)I]FP-CIT SPECT.
    J Neural Transm (Vienna). 2022 May 27. pii: 10.1007/s00702-022-02517.
    PubMed         Abstract available


    Mov Disord


  3. The PSG 32nd Annual Symposium on Etiology, Pathogenesis, and Treatment of Parkinson Disease and Other Movement Disorders.
    Mov Disord. 2022;37 Suppl 1:S1-S36.
    PubMed        

  4. HOBSON DE, Del Bigio MR
    Beekeeper Parkinsonism.
    Mov Disord. 2022 May 31. doi: 10.1002/mds.29076.
    PubMed        


    Neurobiol Dis

  5. VOIGT RM, Wang Z, Brown JM, Engen PA, et al
    Gut microbial metabolites in Parkinson's disease: Association with lifestyle, disease characteristics, and treatment status.
    Neurobiol Dis. 2022 May 30:105780. doi: 10.1016/j.nbd.2022.105780.
    PubMed         Abstract available

  6. SONG B, Feldmann JW, Cao S, Feitosa M, et al
    A Pitx3-deficient developmental mouse model for fine motor, olfactory, and gastrointestinal symptoms of Parkinson's disease.
    Neurobiol Dis. 2022 May 27:105777. doi: 10.1016/j.nbd.2022.105777.
    PubMed         Abstract available


    Neurologia (Engl Ed)

  7. FERNANDEZ-ESPEJO E
    Microorganisms associated with increased risk of Parkinson's disease.
    Neurologia (Engl Ed). 2022 May 26. pii: S2173-5808(22)00054.
    PubMed         Abstract available

  8. FERNANDEZ-PAJARIN G, Sesar A, Jimenez-Martin I, Ares B, et al
    Progression and treatment of a series of patients with advanced LRRK2-associated Parkinson's disease.
    Neurologia (Engl Ed). 2022 May 26. pii: S2173-5808(22)00055.
    PubMed         Abstract available


    Neurology

  9. TALMAN L
    Quality of Life for Patients With Parkinson Disease.
    Neurology. 2022;98:e2293-e2295.
    PubMed        


    Neuron

  10. PANICKER N, Kam TI, Wang H, Neifert S, et al
    Neuronal NLRP3 is a parkin substrate that drives neurodegeneration in Parkinson's disease.
    Neuron. 2022 May 25. pii: S0896-6273(22)00450.
    PubMed         Abstract available


    Rev Neurol

  11. FERNANDEZ-PAJARIN G, Martin-Jimenez I, Ares-Pensado B, Sesar-Ignacio A, et al
    [Apomorphine and frontal dysfunction in Parkinson's disease].
    Rev Neurol. 2022;74:367-371.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: